| Dr Ali M Sayed, MD | |
|
125 King Ave Ste 200, Athens, GA 30606-6710 | |
| (706) 369-4478 | |
| (706) 353-6639 |
| Full Name | Dr Ali M Sayed |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 21 Years |
| Location | 125 King Ave Ste 200, Athens, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1548410400 | NPI | - | NPPES |
| 003205621B | Medicaid | GA | |
| G01512A | Other | GA | MEDICARE PTAN |
| 003205621A | Medicaid | GA |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital | Atlanta, GA | Hospital |
| St. Mary's Good Samaritan Hospital | Greensboro, GA | Hospital |
| Piedmont Athens Regional Medical Center | Athens, GA | Hospital |
| Morgan Medical Center | Madison, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Nsh Cancer Institute Professional Services G Llc | 0840443164 | 104 |
News Archive
Synergetics USA has announced the following update to its shareholders on the status of the pending Iridex patent infringement lawsuit.
The costs of drinking and driving are all too apparent, with alcohol involved in 41 percent of all motor vehicle crash fatalities in 2006. In addition to the mortality and morbidity associated with drinking and driving, the economic impact of alcohol impaired driving is considerable, estimated at $51 billion, with medical costs accounting for 15 percent of that figure.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the neuropathic pain drug market - driven by the launches of several novel therapies - will increase from $6 billion in 2008 to $9.7 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Inhibikase Therapeutics, a specialty pharmaceutical company based in Atlanta, Georgia, will discuss simultaneous antiviral and antibacterial activity from small molecule agents at the 2009 BIOCOM Investor Conference. Employing a host-factor targeted approach, Inhibikase will illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases in humans.
Doctors should consider radiosurgery earlier for patients with severe facial pain, according to a new study in the International Journal of Radiation Oncology Biology Physics (the "Red Journal") - the official journal of the American Society for Radiation Oncology.
› Verified 3 days ago
| Entity Name | Nsh Cancer Institute Professional Services G Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144571381 PECOS PAC ID: 0840443164 Enrollment ID: O20130128000225 |
News Archive
Synergetics USA has announced the following update to its shareholders on the status of the pending Iridex patent infringement lawsuit.
The costs of drinking and driving are all too apparent, with alcohol involved in 41 percent of all motor vehicle crash fatalities in 2006. In addition to the mortality and morbidity associated with drinking and driving, the economic impact of alcohol impaired driving is considerable, estimated at $51 billion, with medical costs accounting for 15 percent of that figure.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the neuropathic pain drug market - driven by the launches of several novel therapies - will increase from $6 billion in 2008 to $9.7 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Inhibikase Therapeutics, a specialty pharmaceutical company based in Atlanta, Georgia, will discuss simultaneous antiviral and antibacterial activity from small molecule agents at the 2009 BIOCOM Investor Conference. Employing a host-factor targeted approach, Inhibikase will illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases in humans.
Doctors should consider radiosurgery earlier for patients with severe facial pain, according to a new study in the International Journal of Radiation Oncology Biology Physics (the "Red Journal") - the official journal of the American Society for Radiation Oncology.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ali M Sayed, MD 1835 Savoy Dr Ste 300, Atlanta, GA 30341-1071 Ph: (706) 369-4478 | Dr Ali M Sayed, MD 125 King Ave Ste 200, Athens, GA 30606-6710 Ph: (706) 369-4478 |
News Archive
Synergetics USA has announced the following update to its shareholders on the status of the pending Iridex patent infringement lawsuit.
The costs of drinking and driving are all too apparent, with alcohol involved in 41 percent of all motor vehicle crash fatalities in 2006. In addition to the mortality and morbidity associated with drinking and driving, the economic impact of alcohol impaired driving is considerable, estimated at $51 billion, with medical costs accounting for 15 percent of that figure.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the neuropathic pain drug market - driven by the launches of several novel therapies - will increase from $6 billion in 2008 to $9.7 billion in 2018 in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
Inhibikase Therapeutics, a specialty pharmaceutical company based in Atlanta, Georgia, will discuss simultaneous antiviral and antibacterial activity from small molecule agents at the 2009 BIOCOM Investor Conference. Employing a host-factor targeted approach, Inhibikase will illustrate the utility of IkT-001 and IkT-041 to treat multiple infectious diseases in humans.
Doctors should consider radiosurgery earlier for patients with severe facial pain, according to a new study in the International Journal of Radiation Oncology Biology Physics (the "Red Journal") - the official journal of the American Society for Radiation Oncology.
› Verified 3 days ago
Bannur Ramanna Nandeesh, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-5076 | |
Krupal Jay Hari, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 242 King Avenue, Suite 210, Athens, GA 30606 Phone: 706-475-1700 Fax: 706-475-1790 | |
Mr. Ashwin Thatti, Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1500 Oglethorpe Ave Ste 500c, Athens, GA 30606 Phone: 706-546-7484 | |
Dr. Stephen William Wilde, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 700 Sunset Dr, Suite 501, Athens, GA 30606 Phone: 706-208-0065 Fax: 706-459-8693 | |
Dr. James S Miller, MD Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-1700 Fax: 706-546-1787 | |
Dr. Paul Peteet, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 55 Carlton St, Athens, GA 30602 Phone: 706-542-8621 Fax: 706-583-0217 | |
Diana T Blake, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2470 Daniells Bridge Rd Ste 231, Athens, GA 30606 Phone: 706-769-3362 Fax: 706-769-5675 |